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Abstract: The major constituent from the hexane extract of the seeds of P. insignis is GFC (garcinielliptone FC). Doses of 25, 50 
and 75 mg/kg of GFC were aseptically suspended in 0.05% Tween 80 dissolved in 0.9% saline (vehicle) and orally administered for 
30, 90 and 120 consecutive days to adult Swiss mice. In this work, the repeated oral administration, in animals of both sexes, 
demonstrates that this compound is not able to induce mortality and/or behavioral changes in adult mice. In addition, body weight 
gain, feed intake and disposal of excreta were not altered by the administration of this compound with repeated doses. Furthermore, 
no differences in weight and macroscopic structure of the brain, liver, kidney, lung, heart and spleen between groups of male and 
female adult mice were observed after treatment. During the periods of treatment, GFC produced no significant changes on 
haematological and biochemical parameters in male and female mice treated with all doses used. The aim of this study was to 
investigate the toxicological potential of GFC through behavioral, hematological, biochemical and morphological parameters in 
animals in order to ensure the safe use of Platonia insignis in folk medicine. 
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Abbreviations: ALT, alanine aminotransferase; ANOVA, variance; AST, aspartate minotransferase; CHCl3-MeOH, 
Chloroform-Methanol; ECEA, Ethics Committee on Experimental Animals; EtOAc, ethyl acetate; FAPEPI, Research Supporting 
Foundation of the State of Piaui; GFC, Garcinielliptone FC; HB, hemoglobin; i.p., intraperitoneally; MCH, mean corpuscular 
hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MM, male mice; FM, female 
mice; OECD, Organization of Economic Cooperation and Development’s; o.r., orally; RBCs, Hemacias; S.E.M., Standard Error of 
Mean; TLC, thin layer chromatography; UFPI, Federal University of Piaui; USA, United States of America. 
 
1. Introduction 
Platonia insignis Mart is a monotype specie that 
belongs to the Clusioideae family, popularly known as 
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“bacuri”. It is a fruit and timber specie original from 
the western Brazilian Amazon, particularly from the 
State of Pará [1], widely used in folk medicine. The 
oil from the seeds of P. insignis has been used to treat 
various skin diseases in humans and animals as well 
as the decoction of seeds has been used for the 
treatment of diarrhea and inflammatory diseases in 
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humans [2, 3].  
Previous studies dealing with the chemical 
composition of the plant family Clusiaceae show that 
these species are rich in polyisoprenylated xanthones 
and benzophenones [1, 4-6]. Among these studies, 
from the hexane extract of the P. insignis seeds, it was 
isolated a pair of polycyclic polyisoprenylated 
tautomers, named Garcinielliptone FC (Fig. 1). This 
compound is unprecedent, in the genus Platonia. 
These types of compounds and other benzophenone 
polyisoprenylated structures, such as 
2,4,6-trihydroxy-benzophenone and alkyl aryl ketones 
have also been isolated from species of the genus 
Garcinia, Clusia and Rheedia (clusioideae subfamily). 
They are not only found in the resin, but also in 
various organs of the plants, which reinforces the need 
for developing this study since these compounds may 
exhibit pharmacological activity of interest in 
pharmaceutical, cosmetic and/or food industry/field 
[7-9]. 
These compounds have shown various 
pharmacological activities, which can be highlighted 
the antidepressant [10]; antioxidant [1]; antifungal 
[11], cytotoxic [12], antiretroviral [11], antibacterial 
[13] and anticonvulsant [1] effects, suggesting once 
again that knowledge of its toxicity profile can expand 
its safer use. Because, as described in the literature, 
any substance can be considered as a toxic agent [14]. 
In this context, the aim of this study was to conduct 
an experimental protocol with repeated doses of GFC 
in mice to investigate its toxicological potential 
through behavioral, hematological, biochemical and 
morphological parameters in animals treated with this 
compound. The studies were made in order to ensure 
the safe use of Platonia insignis in folk medicine. 
2. Materials and Methods 
2.1 Plant Material, Extraction and Isolation  
The seeds were obtained from fruits of specimens 
collected in the city of Barras, Piaui, Brazil, in March 
2009, a voucher specimen (ICN TEPB27164) was 
deposited in the Herbarium Graziella Barroso, Federal 
University of Piaui. At first, 848.2 g of the seeds were 
dried at 55 °C and submitted to extraction (soxhlet) 
with hexane (63%). Then, the hexane extract was 
subjected to silica gel eluted with hexane containing 
increasing amounts of ethyl acetate and washed with 
methanol to end the process. One of the fractions was 
purified by TLC (thin layer chromatography) eluted 
with CHCl3-CH3OH (9:1), obtaining 22 mg of GFC 
which was identified by means of spectroscopic 
methods [1]. 
2.2 Drugs and Dosages 
The GFC was emulsified in 0.05% Tween 80 
(Sigma Chem. Co., St. Louis, MO, USA) diluted in 0.9% 
 
 
Fig. 1  Tautomeric forms of  
8,8-dimethyl-1-(3,4-dihydroxybenzoyl)-2(4)-hydroxy-3,5-di(,-dimethylallyl)-7-(2-isopropenylhex-5-enyl)-7α-H-trans-bicyclo
[3.3.1] nona-2-en-4,9-dione (Garcinielliptone FC a) 2-hydroxyl and b) 4 hydroxyl).  
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saline (vehicle) and administered orally in selected 
doses (25, 50 e 75 mg/kg), calculated to enable the 
injection of 0.1 mL per 10 g weight of each mouse. 
The controls received vehicle with the same volume 
by the same route as the other treated groups. 
2.3 Animals 
All animals were maintained in a controlled 
temperature (26 ± 1 °C) and a cycle of 12 h light/dark. 
The animals had free access to food and water. All 
experiments were performed in accordance with the 
Guide for the Care and Use of Laboratory Animals, 
Department of Health and Human Services, 
Washington DC, 1985. The project was approved by 
the Ethics Committee on Experimental Animals of the 
Federal University of Piaui (ECEA/UFPI # 078/2012). 
2.4 Evaluation of the Toxicological Potential 
2.4.1 Behavioral Screening (Hippocratic Screening) 
The method of Hippocratic Screening for evaluation 
of toxicity has been a very useful and commonly used 
method for the preliminary screening of plants and/or 
to detect chemical compounds with pharmacological 
and toxicological activities [15, 16] as well as the 
study of physiologic daily habits. 
Thirty mice between males and females were 
divided into three groups of 10 animals weighing 
25-30 g for each dose (n = 10). The animals were 
treated orally for 30, 90 and 120 consecutive days 
with repeated doses of 25, 50 e 75 mg/kg of GFC. 
During the treatment period, systematic behavioral 
observations were conducted to evaluate the 
Hippocratic Screening, which provides a general 
estimate of the toxicity of the substance on the state of 
consciousness and general provision, activity and 
coordination of the motor system, reflexes and 
activities on the central and autonomic nervous system 
[17, 18]. 
The parameters: general activity, vocal fremitus, 
irritability, touch response, contortion, righting reflex, 
muscle tone, strength to grasp, ataxia, atrial reflex, 
corneal reflex, tremors, convulsions, straub tail on, 
hypnosis, anesthesia, lacrimation, ptosis, urination, 
defecation, piloerection, hypothermia, breathing, 
cyanosis, hyperemia, death; were evaluated every two 
days during the period of 30, 90 and 120 days. The 
administration of the GFC was evaluated daily until 
the last day of administration. Signs of toxicity, time 
of onset, intensity, duration and progression were 
recorded for later analysis. 
2.4.2 Repeated Doses 
Body weight and nutritional status of the animals 
were quantified and analyzed. The mice were placed 
individually in cages and acclimated for a period of 15 
days. Groups of animals (n = 10) were treated daily at 
the same time, orally (gavage; o.r.) at doses of 25, 50 
and 75 mg/kg of GFC or vehicle (0.1 mL/100 g, o.r.) 
over a period of 30, 90 and 120 days. The following 
measures were recorded daily for each animal: the 
volume of water consumed (mL), the weight of feed 
consumed (g), the volume of urine excreted (mL) and 
weight of stools produced (g) besides behavioral 
changes throughout the study of Cunha et al. [19]. At 
time intervals of seven days, the animals were 
weighed for determination of weight gain during the 
experimental period of 120 days. 
2.4.2 Evaluation of Hematological and Biochemical 
Parameters 
Forty mice divided into four groups of 10 animals 
(n = 10) were treated daily orally for up to 120 days, 
with vehicle (Tween 80 0.05% dissolved in saline 
0.9%, control group) and the doses of 25, 50 e 75 
mg/kg of GFC, respectively GFC25, GFC50 and GFC75 
groups. 
After each treatment period, the animals were 
anesthetized with sodium pentobarbital (40 mg/kg, i.p.) 
and blood collection was performed by puncture of the 
orbital venous plexus using a needle and syringe 
microhematocrit tubes. The blood was placed into two 
kinds of tube: one with anticoagulant hemoglobin 
(Laborlab®) for determination of hematologic 
parameters and the other without anticoagulant to 
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obtain serum for assessment of biochemical 
parameters. 
The values for erythrocytes, leukocytes, platelets, 
hemoglobin, hematocrit and RBC indices MCV (mean 
corpuscular volume), MCH (mean corpuscular 
hemoglobin) and MCHC (mean corpuscular 
hemoglobin concentration) were determined 
immediately after collection using an automated 
analyzer hematologic cell 120/Hematology Siemens 
Advia. The differential leukocyte count was 
performed in extensions stained with 
May-Grünwald-Giemsa. In each experiment, 100 cells 
were analyzed and counted. 
For biochemical analysis, the material was 
centrifuged at 3500 rpm for 10 minutes and then 
determined the glucose, urea, creatinine, AST 
(aspartate aminotransferase), ALT (alanine 
aminotransferase), total cholesterol, triglycerides, total 
and direct bilirubin uric acid. Assays were performed 
in automatic machine LabMax 240 (Labtest) with 
commercial systems Labtest®. 
2.4.3 Gross Morphological Analysis 
After the treatment period of 120 days with 
repeated doses of GFC, animals received 40 mg/kg 
sodium pentobarbital. According to the protocol of 
Cornell University/Cornell Center for Animal 
Resources and Education as described by Flecknell 
[20] and Kohn et al. [21], mice were euthanized by 
cervical dislocation to perform the macroscopic 
evaluation. Therefore, the gross morphological 
analysis of the naked bodies view was held. In 
addition, there must had weighted the liver, lung, heart, 
kidney, brain and spleen to determine the relative 
weights to check whether there was gross 
morphological changes in the major organs evaluated. 
2.5 Statistical Analysis 
Results of hematological and biochemical 
parameters were expressed as mean ± S.E.M. 
(Standard Error of Mean). Data were evaluated using 
variance analysis (ANOVA) followed by t-Student 
Newman Keuls test as post hoc test (P < 0.05). An 
estimate of variance was applied for comparison 
between treated and control groups for each gender 
group. 
3. Results 
3.1 Study of Toxicity at 30, 90 and 120 Days, 
Hippocratic Screening 
One of the methodologies used to assess the toxic 
potential of the GFC administered in repeated doses 
was the analysis of the animals according to the 
Hippocratic Screening. This technique checks the 
effects produced by a substance as the state of 
awareness and provision, coordination, muscle tone, 
reflexes (ear, corneal), activity of the central nervous 
system and autonomic nervous system activity of the 
animal [18]. 
The Hippocratic Screening of animals treated with 
repeated doses of GFC in 30, 90 120 days are shown 
in Table 1. Physiological signals were kept steadily in 
all three doses, with a slight increase after treatments, 
not significant as clinical signs of toxicity.  
During the study, it was observed that among the 
signs and symptoms that animals presented, there 
were an attendance of straub, piloerection, lack of 
response in the grip of the tail and corneal reflection, 
characteristic manifestations of toxicity but when they 
occur intensely and associated with other suggestive 
parameters of toxic processes. In this study, these 
events were a response to the organic compound 
studied and are not characteristic of toxicity, since 
these events were mild and did not cause mortality in 
animals. 
During the Hippocratic Screening, the increased 
urination and defecation was unobtrusive and may 
have occurred only by simple manipulation of the 
animals after administration of the daily doses, since 
the action of the observer and the change of the eating 
habits can cause these changes [19]. Nonetheless, this 
is considered irrelevant for toxicity studies. 
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(Days) Signs and Symptoms 
Vehicle 30 Absence of signs and symptoms of intoxication. 
90 Absence of signs and symptoms of intoxication. 
120 Absence of signs and symptoms of intoxication. 
GFC25 30 Increased urination and defecation. 
 90 
Increased urination and defecation. Presence of straub and piloerection. Lack of response in 
the grip of the tail. 
 120 
Increased urination and defecation. Presence of straub and piloerection. Lack of response in 
the grip of the tail. 
GFC50 30 Increased urination and defecation. Presence of piloerection. 
 90 
Increased defecation. Presence of straub and piloerection. Lack of response in the grip of the 
tail and corneal reflex. 
 120 
Increased defecation. Presence of straub and piloerection. Lack of response in the grip of the 
tail and corneal reflex. 
GFC75 30 Increased urination and defecation. Presence of straub and piloerection. 
 90 
Increased urination and defecation. Presence of straub and piloerection. Lack of response in 
the grip of the tail and corneal reflex. 
 120 
Increased urination and defecation. Presence of straub and piloerection. Lack of response in 
the grip of the tail and corneal reflex. 
The GFC aseptically emulsified in 0.05% Tween 80 dissolved in 0.9% saline (vehicle) was administered as single oral doses to 
groups of 10 mice. All animals were carefully examined for symptoms of toxicity (behavioral changes and mortality) within 30, 90 
and 120 days, consecutively. Control (Vehicle) 25 mg/kg (GFC (25), 50 mg/kg, GFC (50) e 75 mg/kg (GFC (75)).  
 
However, even with this understanding, the weights 
of the animals, the consumption of water and food and 
excreta presented during the same periods of the 
Hippocratic Screening assessment were measured to 
check possible changes in these parameters with an 
indication of toxicity.  
3.2 Body Weights and Food Consumption of Animals 
During the treatment period, intakes of food (Fig. 2) 
and water (Fig. 3) of animals were analyzed. The 
results showed that after the administration, in any of 
the three doses tested of GFC, food and water 
consumption were not significantly altered. 
Regarding the production of excreta, animals 
treated with GFC during the three doses did not 
achieve significant change compared with the control 
group (Fig. 4), showing weak oscillations according to 
time and dose. 
Body weight of the animals was evaluated, 
considering ingestion, elimination and weigh. The 
results showed no significant changes in these 
parameters even after chronic treatment period or dose 
increasing. There were slight increases for these two 
aspects (Fig. 5). 
3.3 Analysis of Hematological and Biochemical 
Parameters 
Hematological and biochemical parameters are 
useful for the investigation of systemic toxicity in 
animals treated for long periods of time with 
potentially harmful substances [19]. In this study, the 
results of hematology parameters of the animals 
treated with GFC are shown in Tables 2 and 3. The 
data demonstrated that there were no significant 
changes in the groups treated with GFC, when it was 
compared to the control group.  
During the 30 days treatment with GFC there was a 
reduction of 5 and 7% in the MCHC index in male 
mice treated with doses of 50 and 75 mg/kg compared 
with the control group (P < 0.05), respectively. As for 
the females, it was observed a 7% reduction in this 
parameter only after the treatment with the dose of 75 
mg/kg for the same period of observation (P < 0.05). 
During this period of observation, there was a 
reduction of 14.46 and 15 % in the number of 
leukocytes  in male  mice treated  with doses  of 50 and 
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Fig. 2  Effect of oral administration of GFC in repeated doses on the feed intake of the animals.  
Statistical analysis was performed using ANOVA followed by t-Student-Newman Keuls-test as a post hoc test (GFC-Garcinielliptone 
FC: 25 mg/kg, 50 mg/kg and 75 mg/kg). 
 
 
Fig. 3  Effect of oral administration of GFC in repeated doses on the water consumption of animals.  
Statistical analysis was performed using ANOVA followed by t-Student-Newman-Keuls test as a post hoc test (GFC-Garcinielliptone 
FC: 25 mg/kg, 50 mg/kg and 75 mg/kg). 
 
 
Fig. 4  Effect of oral administration of repeated doses of GFC production by animal excreta for 30, 90 and 120 days.  
Statistical analysis was performed using ANOVA followed by t-Student-Newman-Keuls test as a post hoc test (GFC Garcinielliptone 
FC: 25 mg/kg, 50 mg/kg and 75 mg/kg). 
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Fig. 5  Effects of oral administration of GFC in repeated doses on the body weight of animals.  
Statistical analysis was performed using ANOVA followed by t-Student-Newman-Keuls test post hoc test (GFC: 25 mg/kg, 50 mg/kg 
and 75 mg/kg). 
 
75 mg/kg compared with the control group (P < 0.05), 
respectively.  
Furthermore, during treatment with GFC for 90 
days, there was a reduction of 6% on the MCHC index 
in male mice after treatment with a dose of 75 mg/kg 
as compared with the control group (P < 0.05), and 
decreases of 5, 7 and 7% in females on the MCHC 
index after treatment with doses of 25, 50 e 75 mg/kg 
when compared with the group control (P < 0.05) 
respectively. 
Finally, similarly to these results, the administration 
of GFC for 120 days reduced by 3 and 4% in male 
mice and by 7 and 12% in females the MCHC index 
with doses of 50 and 75 mg/kg as compared with the 
control group (P < 0.05), respectively. Moreover, we 
detected a decrease of 25% in the number of 
leukocytes only in female mice after treatment with a 
dose of 50 and 75 mg/kg as compared with the control 
group (P < 0.05). 
The biochemical parameters for animals treated 
with GFC are presented in Tables 4 and 5. Liver 
enzymes were measured in order to check possible 
kidney or liver damage in the experimental animals. 
Our study for toxicity evaluation of GFC determined 
the levels of urea and uric acid in MM (male mice) 
and FM (female mice) vehicle-treated and those 
treated with doses of GFC. After 30, 90 and 120 days 
administration, it was observed a decrease in the level 
of urea at 30 days (MM = 4.8, 4.7 and 6.3%; FM: 4.8, 
5.7 and 3.9%, 90 Days (MM = 4.9, 6.3 and 6.7%; FM: 
6.44, 6.4 and 6.7%) and 120 days (MM = 10.2, 7.9 
and 8.4%; FM: 8.1, 8.0 and 8.4%), with doses 
administered consecutively. The contents of uric acid 
also decreased 30 days (MM = 5.1, 4.1 and 5.1%; FM: 
5.2, 3.5 and 2.6%), 90 Days (MM = 4.1, 5.1 and 4.1%; 
FM: 7.4, 5.2 and 3.9%) and 120 days (MM = 7.6, 6.1 
and 7.1%; FM: 6.1, 5.2 and 8.3%), with doses 
administered sequentially, compared with the control 
group (P < 0.05).  
Similarly, cholesterol and triglycerides levels 
decreased from the groups orally treated with the 
repeated doses of GFC 25, 50 and 75 mg/kg: 
cholesterol levels at 30 days (MM = 14.4, 15.9 and 
9.8%, FM: 16.7, 13.2 and 8.4%), 90 days (MM = 7.8, 
14.7 and 16.5%; FM: 12.0, 15.7 and 17.1%) and 120 
days (MM = 13.4, 17.2 and 17.3%, FM: 23.6, 18.0 and 
11.5%); triglyceride levels, (MM = 10.9% (25 mg/kg), 
FM: 10,3% (25 mg/kg)), 90 days (MM = 8.5% (25 
mg/kg); FM: 12.7% (25 mg/kg)) and 120 days (MM = 
12.5% (25 mg / kg), FM: 16.5% (25 mg/kg)) as 
compared with the control group (P < 0.05). Given 
these effects it can be suggested a beneficial role of this 
polyisoprenylated benzophenone serum in reducing 
triglycerides, that needs to be better evaluated.  
 
 
Table 2  Effect of repeated dose administration of GFC on hematological parameters of animals for 30, 90 and 120 days of treatment. 
  30 Days 90 Days 120 Days 
Parameters 
Control GFC25 GFC50 GFC75 GFC25 GFC50 GFC75 GFC25 GFC50 GFC75 
(Vehicle) (25 mg/kg) (50 mg/kg) (75 mg/kg) (25 mg/kg) (50 mg/kg) (75 mg/kg) (25 mg/kg) (50 mg/kg) (75 mg/kg) 
Males                     
RBCs (mm3) 9.08 ± 0.25 10.32 ± 0.12 10.70 ± 0.72 9.28 ± 0.49 9.10 ± 0.42 9.35 ± 0.67 9.94 ± 0.35 8.40 ± 0.47 9.45 ± 0.55 9.66 ± 0.29 
Hemoglobin (g dL-1) 14.41 ± 0.07 15.91 ± 0.65 15.63 ± 1.10 15.57 ± 0.46 14.41 ± 1.48 15.23 ± 1.62 15.19 ± 2.67 15.34 ± 3.22 15.34 ± 3.45 16.41 ± 2.55 
Hematocrit (%) 43.31 ± 1.17 43.22 ± 3.96 43.51 ± 2.75 42.63 ± 2.25 43.31 ± 2.27 43.54 ± 3.86 46.67 ± 3.67 43.16 ± 2.34 45.16 ± 1.34 44.15 ± 2.43 
VCM (fL) 49.73 ± 0.11 47.32 ± 1.07 48.10 ± 0.78 49.82 ± 1.00 49.45 ± 3.50 48.16 ± 3.67 47.18 ± 2.89 49.37 ± 2.67 48.45 ± 1.65 49.56 ± 2.64 
HCM (pg) 17.58 ± 0.02 17.61 ± 0.37 17.22 ± 0.20 17.90 ± 0.29 18.45 ± 3.78 17.89 ± 2.34 17.89 ± 2.13 16.45 ± 3.45 17.45 ± 2.14 16.58 ± 4.58 
CHCM (g dL-3) 38.87 ± 0.45 37.53 ± 0.53 36.73 ± 0.21ª 36.13 ± 0.42ª 38.15 ± 2.67 37.45 ± 3.56 36.56 ± 3.23ª 38.16 ± 2.34 37.42 ± 1.45ª 37.09 ± 3.17ª 
Platelets (mm3) 445.30 ± 11.05 444.92 ± 12.85 446.83 ± 11.6 446.24 ± 11.9 448. 77 ± 14.09 447.78 ± 12.16 446.23 ± 13.34 447.37 ± 14.18 446.40 ± 12.41 446.48 ± 13.50 
Leukocytes total 
(mm3) 8.02 ± 0.25  7.89 ± 0.25 6.86 ± 0.37ª 6.78 ± 1.14ª 8.23 ± 3.55 8.50 ± 4.56 6.19 ± 3.67ª 8.45 ± 2.34 8.56 ± 1.45 6.51 ± 2.19ª 
Neutrophils (%) 8.45 ± 0.56 8.54 ± 1.45 7.96 ± 2.42 8.46 ± 2.22 8.16 ± 2.04 8.89 ± 2.67 8.67 ± 2.15 8.40 ± 3.34 8.76 ± 2.32 9.43 ± 2.51 
Lymphocytes (%) 74.33 ± 0.04 74.35 ± 0.16 74.36 ± 0.16 74.37 ± 0.06 74.33 ± 3.18 75.70 ± 3.78 75.79 ± 3.42 73.32 ± 4.49 73.34 ± 3.34 74.45 ± 3.10 
Females                     
RBCs (mm3) 9.17 ± 0.56 9.83 ± 0.12 8.74 ± 0.20 8.91 ± 0.95 8.83 ± 0.12 9.74 ± 0.20 9.91 ± 0.95 9.51 ± 0.48 9.32 ± 0.49 9.78 ± 0.71 
Hemoglobin (g dL-1) 15.29 ± 0.19 14.10 ± 2.26 15.50 ± 1.78 16.38 ± 1.24 15.10 ± 2.26 15.50 ± 1.78 16.38 ± 1.24 14.46 ± 3.34 15.10 ± 2.23 15.39 ± 3.14 
Hematocrit (%) 48.18 ± 1.57 47.25 ± 2.75 48.28 ± 3.09 48.60 ± 2.25 47.25 ± 2.75 48.28 ± 3.09 47.60 ± 2.25 47.31 ± 3.18 47.23 ± 2.54 48.84 ± 3.95 
VCM (fL) 52.64 ± 0.10 51.25 ± 2.24 51.46 ± 1.37 52.34 ± 1.87 51.25 ± 2.24 50.46 ± 1.37 51.34 ± 1.87 52.23 ± 2.56 51.35 ± 2.61 52.42 ± 4.16 
HCM (pg) 18.55 ± 0.15 18.20 ± 2.28 18.91 ± 3.67 17.71 ± 2.22 17.20 ± 2.28 17.91 ± 3.67 16.71 ± 2.22 17.27 ± 3.16 18.54 ± 3.16 18.29 ± 2.17 
CHCM (g dL-3) 40.25 ± 0.49 38.23 ± 2.16 39.08 ± 3.39 37.40 ± 2.85ª 38.23 ± 2.16ª 37.40 ± 3.39ª 37.08 ± 2.85ª 38.54 ±3.17 37.29 ± 3.38ª 35.34 ± 4.14ª 
Platelets (mm3) 448.70 ± 14.32 447.15 ± 12.16 446.18 ± 13.29 448.50 ± 14.26 447.15 ± 12.16 445.18 ± 13.29 446.50 ± 12.26 446.34 ± 14.38 447.21 ± 13.35 446.34 ± 14.27 
Leukocytes total 
(mm3) 6.32 ± 0.55  6.30 ± 2.21 6.23 ± 3.20 6.61 ± 2.80 6.31 ± 2.24 5.16 ± 3.36ª 6.58 ± 2.35 6.64 ± 4.17 6.25 ± 3.41 4.74 ± 4.57ª 
Neutrophils (%) 6.47 ± 0.34 6.31 ± 2.28 6.56 ± 3.20 5.35 ± 3.26 6.31 ± 2.28 6.56 ± 3.20 7.35 ± 3.26 6.24 ± 3.47 6.36 ± 3.49 6.24 ± 4.01 
Lymphocytes (%) 72.45 ± 2.45 72.43 ± 2.39 70.18 ± 3.53 70.25 ± 2.59 72.43 ± 2.39 71.18 ± 3.53 71.25 ± 2.59 71.20 ± 4.35 71.41 ± 2.38 72.37 ± 4.09 
VCM (volume corpuscular mean); HCM (Hemoglobin Corpuscular Mean); CHMC (Concentration Hemoglobin Corpuscular Mean); Control (vehicle); GFC (Garcinielliptone FC 






   
Table 3  Effect of repeated dose administration of GFC on biochemical parameters of animals for 30, 90 and 120 days of treatment.  
    30 Days 90 Days 120 Days 
Parameters 
Control GFC25 GFC50 GFC75 GFC25 GFC50 GFC75 GFC25 GFC50 GFC75 
(Vehicle) (25 mg/kg) (50 mg/kg) (75 mg/kg) (25 mg/kg) (50 mg/kg) (75 mg/kg) (25 mg/kg) (50 mg/kg) (75 mg/kg) 
Male                     
Brain (g%) 0.16 ± 0.05 0.15 ± 0.10 0.16 ± 0.13 0.17 ± 0.16 0.15 ± 0.34 0.16 ± 0.45 0.17 ± 0.12 0.15 ± 0.13 0.18 ± 0.11 0.15 ± 0.11 
Spleen (g%) 0.07 ± 0.01 0.06 ± 0.01 0.08 ± 0.03 0.06 ± 0.01 0.07 ± 0.01 0.08 ± 0.03 0.06 ± 0.01 0.08 ± 0.04 0.09 ± 0.01 0.08 ± 0.01 
Heart (g%) 0.15 ± 0.09 0.16 ± 0.07 0.16 ± 0.03 0.15 ± 0.09 0.16 ± 0.07 0.16 ± 0.03 0.15 ± 0.09 0.15 ± 0.01 0.14 ± 0.05 0.15 ± 0.02 
Liver (g%) 0.74 ± 0.18 0.73 ± 0.05 0.75 ± 0.02 0.74 ± 0.18 0.73 ± 0.05 0.75 ± 0.02 0.74 ± 0.18 0.91 ± 0.13 0.87 ± 0.12 0.84 ± 0.03 
Lungs (g%) 0.16 ± 0.02 0.15 ± 0.09 0.17 ± 0.01 0.16 ± 0.02 0.15 ± 0.09 0.17 ± 0.01 0.16 ± 0.02 0.14 ± 0.02 0.15 ± 0.01 0.16 ± 0.01 
Kidneys (g%) 0.09 ± 0.09 0.04 ± 0.03 0.05 ± 0.06 0.05 ± 0.08 0.04 ± 0.03 0.05 ± 0.06 0.05 ± 0.08 0.12 ± 0.01 0.11 ± 0.05 0.10 ± 0.02 
Female                     
Brain (g%) 0.16 ± 0.01 0.15 ± 0.09 0.16 ± 0.09 0.16 ± 0.11 0.15 ± 0.09 0.16 ± 0.09 0.16 ± 0.11 0.18 ± 0.10 0.17 ± 0.12 0.16 ± 0.12 
Spleen (g%) 0.08 ± 0.01 0.06 ± 0.01 0.07 ± 0.02 0.07 ± 0.02 0.06 ± 0.01 0.07 ± 0.02 0.07 ± 0.02 0.07 ± 0.02 0.08 ± 0.03 0.09 ± 0.02 
Heart (g%) 0.15 ± 0.09 0.14 ± 0.01 0.15 ± 0.03 0.15 ± 0.03 0.14 ± 0.01 0.15 ± 0.03 0.15 ± 0.03 0.13 ± 0.08 0.13 ± 0.01 0.14 ± 0.03 
Liver (g%) 0.74 ± 0.18 0.74 ± 0.20 0.76 ± 0.08 0.76 ± 0.08 0.74 ± 0.20 0.76 ± 0.08 0.76 ± 0.08 0.69 ± 0.03 0.72 ± 0.07 0.71 ± 0.01 
Lungs (g%) 0.16 ± 0.02 0.15 ± 0.10 0.15 ± 0.05 0.15 ± 0.05 0.15 ± 0.10 0.15 ± 0.05 0.15 ± 0.05 0.13 ± 0.02 0.15 ± 0.02 0.14 ± 0.03 
Kidneys (g%) 0.09 ± 0.09 0.04 ± 0.03 0.05 ± 0.06 0.05 ± 0.06 0.04 ± 0.03 0.05 ± 0.06 0.05 ± 0.06 0.04 ± 0.01 0.05 ± 0.05 0.04 ± 0.02 
Table 4  Effects of GFC after administration for 30, 90 and 120 days on the weights of the organs of Swiss mice males and females. 
    30 Days 90 Days 120 Days 
Parameters 
Control GFC25 GFC50 GFC75 GFC25 GFC50 GFC75 GFC25 GFC50 GFC75 
(Vehicle) (25 mg/kg) (50 mg/kg) (75 mg/kg) (25 mg/kg) (50 mg/kg) (75 mg/kg) (25 mg/kg) (50 mg/kg) (75 mg/kg) 
Male                     
Brain (g%) 0.16 ± 0.05 0.15 ± 0.10 0.16 ± 0.13 0.17 ± 0.16 0.15 ± 0.34 0.16 ± 0.45 0.17 ± 0.12 0.15 ± 0.13 0.18 ± 0.11 0.15 ± 0.11 
Spleen (g%) 0.07 ± 0.01 0.06 ± 0.01 0.08 ± 0.03 0.06 ± 0.01 0.07 ± 0.01 0.08 ± 0.03 0.06 ± 0.01 0.08 ± 0.04 0.09 ± 0.01 0.08 ± 0.01 
Heart (g%) 0.15 ± 0.09 0.16 ± 0.07 0.16 ± 0.03 0.15 ± 0.09 0.16 ± 0.07 0.16 ± 0.03 0.15 ± 0.09 0.15 ± 0.01 0.14 ± 0.05 0.15 ± 0.02 
Liver (g%) 0.74 ± 0.18 0.73 ± 0.05 0.75 ± 0.02 0.74 ± 0.18 0.73 ± 0.05 0.75 ± 0.02 0.74 ± 0.18 0.91 ± 0.13 0.87 ± 0.12 0.84 ± 0.03 
Lungs (g%) 0.16 ± 0.02 0.15 ± 0.09 0.17 ± 0.01 0.16 ± 0.02 0.15 ± 0.09 0.17 ± 0.01 0.16 ± 0.02 0.14 ± 0.02 0.15 ± 0.01 0.16 ± 0.01 
Kidneys (g%) 0.09 ± 0.09 0.04 ± 0.03 0.05 ± 0.06 0.05 ± 0.08 0.04 ± 0.03 0.05 ± 0.06 0.05 ± 0.08 0.12 ± 0.01 0.11 ± 0.05 0.10 ± 0.02 
Female                     
Brain (g%) 0.16 ± 0.01 0.15 ± 0.09 0.16 ± 0.09 0.16 ± 0.11 0.15 ± 0.09 0.16 ± 0.09 0.16 ± 0.11 0.18 ± 0.10 0.17 ± 0.12 0.16 ± 0.12 
Spleen (g%) 0.08 ± 0.01 0.06 ± 0.01 0.07 ± 0.02 0.07 ± 0.02 0.06 ± 0.01 0.07 ± 0.02 0.07 ± 0.02 0.07 ± 0.02 0.08 ± 0.03 0.09 ± 0.02 
Heart (g%) 0.15 ± 0.09 0.14 ± 0.01 0.15 ± 0.03 0.15 ± 0.03 0.14 ± 0.01 0.15 ± 0.03 0.15 ± 0.03 0.13 ± 0.08 0.13 ± 0.01 0.14 ± 0.03 
Liver (g%) 0.74 ± 0.18 0.74 ± 0.20 0.76 ± 0.08 0.76 ± 0.08 0.74 ± 0.20 0.76 ± 0.08 0.76 ± 0.08 0.69 ± 0.03 0.72 ± 0.07 0.71 ± 0.01 
Lungs (g%) 0.16 ± 0.02 0.15 ± 0.10 0.15 ± 0.05 0.15 ± 0.05 0.15 ± 0.10 0.15 ± 0.05 0.15 ± 0.05 0.13 ± 0.02 0.15 ± 0.02 0.14 ± 0.03 
Kidneys (g%) 0.09 ± 0.09 0.04 ± 0.03 0.05 ± 0.06 0.05 ± 0.06 0.04 ± 0.03 0.05 ± 0.06 0.05 ± 0.06 0.04 ± 0.01 0.05 ± 0.05 0.04 ± 0.02 
The values represent the mean + S.E.M. (n = 10) animals. “%” represents the relative weight calculated based on the absolute organ weight (g) the value of live animal weight (g) x 
100. P < 0.05 compared to the control group (one-way ANOVA). 
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In turn, the concentration of ALT was decreased 30 
days (MM = 8.6 and 8.4%, FM: 8.2 and 8.0%), 90 
days (MM = 8.2 and 8.3%, FM: 10.4% and 9.5) and 
120 days (MM = 9.8 and 7.2%, FM: 13.9 and 9.7%), 
only by the doses of 25 and 50 mg/kg, respectively, 
compared with the control group (P < 0.05). Similarly, 
there was a decrease on AST, 30 days (MM = 2.9 and 
3.5%; FM: 8.05% and 5.6%), 90 days (CM = 2.3 and 
4.0%, FM: 12.7% and 8.0%) and 120 days (MM = 6.0 
and 4.9%, FM: 16.2 and 9.2%); at doses of 25 and 50 
mg/kg compared with the control group (P < 0.05). 
For this reason we suggest that dose increasing does 
not produce an increase in toxicity, since the observed 
changes in AST and ALT were detected with lower 
doses. 
3.4 Gross Morphological Analysis 
In toxicity studies of repeated doses the main 
parameters evaluated are the general toxic signs, 
dietary changes, laboratory aspects and pathologic 
evaluation and behavioral [22]. 
In macroscopic anatomical review of the main 
dissected organs of male and female mice which 
underwent the treatment with repeated doses of GFC 
(animals Table 4), did not show significant changes 
compared to the control group (P < 0.05).  
Additionally, there was no significant difference in 
the weights of the major organs (brain, spleen, heart, 
liver, lung and kidney) of male and female animals 
treated orally with doses of 25, 50 e 75 mg/kg of GFC 
compared to the control group. The dose also did not 
have a deleterious effect on the organs analyzed after 
treatment with repeated doses. 
4. Discussion 
The acute or chronic evaluation of the toxicity of 
bioactive compounds is of great relevance and interest 
for the pharmaceutical, cosmetic and/or food industry. 
Because they may interfere with several biological 
mechanisms, including the production of blood cells 
or damage to major organs that reveal important role 
in vital functions of the organism with 
biotransformation and/or excretion [23]. These data 
suggest that the toxicological safety profile of 
medicinal plants should be drawn, since its use in folk 
medicine is increasingly carried out by the Brazilian 
population, particularly the inhabitants of the state of 
Piaui, which has easy access to P. insignis and 
products derived from parts of the plant of this species. 
Furthermore, the safety assessment on the use of 
herbal medicines has recently been questioned due to 
reports of deaths and diseases, which reinforces the 
need for the present study [24, 25]. 
In the present study, complementing tests on the 
acute toxicity of a single dose of GFC were made [26] 
by oral administration repeated doses of GFC. This 
study was carried out with the aim of evaluating the 
qualitative and quantitative effects for a long period of 
exposure, providing latency for the installation of 
toxic effects and the consequent appearance after the 
accumulation of the substance in the body during 
preclinical trials.  
Literature has demonstrated numerous toxicological 
studies with plant extracts or isolated compounds from 
plants with therapeutic effect, which makes it 
increasingly necessary to establish parameters for 
toxicity to other species used in Brazilian folk 
medicine [24, 27]. The species P. insignis cannot be 
considered an herbal yet, but the GFC isolated from 
the hexane extract of its seeds has been used in 
various experimental protocols and has demonstrated 
several biological properties such as 
anti-inflammatory [28], antioxidant [1, 29], 
antileishmanial, cytotoxic [30] and vasorelaxing 
properties in rat mesenteric artery [31]. These data and 
the present study are useful to provide more 
information to strengthen the rational therapy and 
safety margins of pharmaceutical, cosmetic and/or 
food products originated from this species, such as, 
folk juices, ice creams, jellies, among others by the 
Brazilian Northeast population. 
In this context, acute toxicity with repeated doses 
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makes reference to the cumulative adverse effects of 
substances administration, preferably orally, in a 
limited period of time (15-30 days) [32]. In our study, 
administration of the substance GFC for 30 days in 
both sexes, demonstrated that this compound is not 
able to induce mortality and/or changes in behavior in 
adult mice. Moreover, body weight gain, feed intake 
and excreta disposal were not altered by acute 
administration with repeated doses of GFC. Our 
results confirm data found for the species of the genus 
Garcinia which belongs to the same family of P. 
insignis. 
The studies with repeated doses for 30, 90 and 120 
consecutive days are differentiated by the period of 
exposure of the animals to the GFC, aiming to verify 
toxicological effects for a long exposure on 
biochemical, hematological and physiological 
parameters of male and female adult mice [33]. 
Regarding the consumption of food and water, there 
were no significant differences on these parameters 
over the days of treatment as well as the volume of 
excreta was proportional to ingestion, suggesting the 
absence of interference of GFC on both parameters 
and on the main bodies’ responses for metabolism and 
excretion. 
The changes in body mass in studies of long-term 
toxicity are important indicators of adverse effects of a 
substance in animal’s laboratory [34, 35]. By means 
of this parameter it was possible to verify that, after 
repeated dosing, GFC increased the body weight of 
the animals, indicating a minimal or no degree of 
toxicity of this compound. As a general rule, most 
investigators consider the gain or loss of body weight 
is of toxicological significance if the reduction is at 
least by 10% compared to the average of the control 
group [36, 37]. We can stress that this compound can 
be considered slightly toxic and therefore safe to be 
used in industrial process for obtaining technological 
products for human and/or animal medical practice 
In our study through the Hippocratic Screening, a 
previous screening test useful in the evaluation of 
pharmacological and toxicological activities [15, 19, 
38], no changes were detected in general activity, 
awareness and sensitivity of male and female mice 
treated with doses of GFC in 25, 50 e 75 mg/kg. In 
addition, there were subtle changes on the autonomic 
nervous system and the absence of feces in individual 
during the treatment, suggesting a possible presence 
of mild constipation. However, it is notable that 
despite this observation, the animals in groups treated 
with GFC and the control group were uniformly 
healthy at the end of the administration period and in 
each of the experimental protocols, suggesting a mild 
toxicity for this compound isolated from P. insignis. 
In addition, to evaluate the toxicity parameters, 
Hippocratic Screening is important to consider the 
effects of GFC on the hematopoietic system, which is 
one of the most sensitive target for toxic compounds 
and is an important index for the physiological and 
pathological state of rodents. Moreover, changes in 
blood profile usually provide vital information about 
the body's response to tissue injury [39]. Daily 
administration of GFC for 120 days produced no 
significant changes in hematological parameters of 
male and female mice treated at all doses, and the 
changes found may be considered toxicologically 
irrelevant as they were within the limits of references, 
demonstrating the slight toxicity of this compound 
[40]. These data also suggest that this compound 
cannot exhibit toxic effects on the hematopoietic 
system, ensuring safe use of this substance in animals 
and generating promising future expectations for 
clinical studies. 
Although, a general model of the biochemical 
profile of the animals were within the reference values 
[26], there were exceptions for urea, uric acid, 
triglycerides, cholesterol, AST and ALT. The 
reduction of urea and uric acid in plasma levels 
indicate an improvement on renal function, suggesting 
GFC can be evaluated in experimental models that 
detect kidney failure, to ensure that it can be used 
during a treatment of acute renal failure besides GFC 
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can also be applied in order to produce a reduction in 
protein catabolism when its needed in some 
pathological conditions [41]. On the other hand, the 
increase in plasma levels of urea and creatinine 
provides evidence of renal overload, acute renal 
failure and increased protein catabolism [42, 43]. In 
this study, a decrease in the serum levels of urea and 
uric acid were observed in the groups treated with 
GFC for 30, 90 and 120 days. Thus, it can be 
suggested that its use can be made safely, since no 
renal overload was observed in the mice.  
In addition to these results, with regard to the 
biochemical parameters, cholesterol and total 
triglyceride levels were reduced in male and female 
mice treated with GFC for 30, 90 and 120 days. 
However, a pharmacological research on the possible 
hypolipidemic effect is required, since the doses were 
used to identify toxic parameters [44]. The assessment 
of the effects of the GFC on the biochemical 
parameters, the analysis of serum aminotransferase 
enzymes (ALT and AST) are important indicators of 
lesions in liver cells [26]. GFC does not cause any 
damage to the liver without interfering with the 
normal activity of these enzymes [44, 45]. The present 
study suggests that the use of GFC for 30, 90 and 120 
cannot induce hepatotoxicity, since a significant 
reduction of AST and ALT were observed, suggesting 
that the compound may induce a hepatoprotective 
effect, which needs to be better investigated [43]. 
Complementing the toxicological evaluation, it is 
important to perform a macroscopic morphological 
study, which is an important index to diagnose 
whether a body has been exposed to an injury, and can 
be done by calculating the ratio between the organ 
weights versus body weight of the animal [46]. In our 
study, no differences in weight and macroscopic 
structure of the brain, liver, kidney, lung, heart and 
spleen between groups of adult male and female mice 
treated with doses of GFC at 25, 50 e 75 mg/kg for 30, 
90 and 120 days were observed when compared to the 
control group [27]. 
Our observations indicate that the polyisoprenylated 
benzophenones in GFC have a wide margin of safety 
in experimental animals commonly used in preclinical 
studies with emphasis on evaluation of toxicity. 
However, despite the knowledge of mild toxicity of 
GFC established in this study, it may be suggested 
that further studies should be conducted as in-depth 
investigation of hyper cholesterolemia in animals in 
order to prove the findings and advance the 
assessment of the safety use of GFC for the design of 
pharmaceutical, cosmetic and/or food formulations, 
since the species which GFC was isolated from is 
widely used in cooking and in popular medicine in 
Northeast Brazil. 
5. Conclusions 
These results indicate that treatment with repeated 
doses of GFC showed no haematological and 
biochemical toxicity, particularly in hepatic and renal 
parameters. In addition, GFC reduced triglyceride 
levels, which need to be investigated in animal models 
of hypercholesterolemia. Thus, in our study, the oral 
administration of GFC at 25, 50 and 75 mg/kg for 30, 
90 and 120 days, in both sexes, demonstrates that the 
polyisoprenylated benzophenones in GFC have a good 
margin of safety in experimental animals commonly 
used in preclinical studies with emphasis on 
evaluation of toxicity. 
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